Search by Drug Name or NDC
NDC 76385-0142-05 Chloroquine phosphate 250 mg/1 Details
Chloroquine phosphate 250 mg/1
Chloroquine phosphate is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayshore Pharmaceuticals LLC. The primary component is CHLOROQUINE PHOSPHATE.
MedlinePlus Drug Summary
Chloroquine phosphate is used to prevent and treat malaria. It is also used to treat amebiasis. Chloroquine phosphate is in a class of drugs called antimalarials and amebicides. It works by killing the organisms that cause malaria and amebiasis.
Related Packages: 76385-0142-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Chloroquine
Product Information
| NDC | 76385-0142 |
|---|---|
| Product ID | 76385-142_fd0b69cf-23b8-6b35-e053-6394a90a7e47 |
| Associated GPIs | 13000010200305 |
| GCN Sequence Number | 009575 |
| GCN Sequence Number Description | chloroquine phosphate TABLET 250 MG ORAL |
| HIC3 | W4A |
| HIC3 Description | ANTIMALARIAL DRUGS |
| GCN | 42890 |
| HICL Sequence Number | 004147 |
| HICL Sequence Number Description | CHLOROQUINE PHOSPHATE |
| Brand/Generic | Generic |
| Proprietary Name | Chloroquine phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chloroquine phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | CHLOROQUINE PHOSPHATE |
| Labeler Name | Bayshore Pharmaceuticals LLC |
| Pharmaceutical Class | Antimalarial [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090610 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 76385-0142-05 (76385014205)
| NDC Package Code | 76385-142-05 |
|---|---|
| Billing NDC | 76385014205 |
| Package | 50 TABLET, FILM COATED in 1 BOTTLE (76385-142-05) |
| Marketing Start Date | 2020-04-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |